Radiopharmaceuticals for diagnosis. [Final] report, 1 January 1991--31 December 1993

Technical Report · Tue Jun 01 00:00:00 EDT 1993

DOI:https://doi.org/10.2172/10107772· OSTI ID:10107772

Kuhl, D E

Since 1987, this grant has supported the development of new radiochemical methods for use with short-lived, positron-emitting radionuclides; new laboratory techniques for radiochemical syntheses; and development of new radiopharmaceuticals which will be of use in Positron Emission Tomography. For the period 1 January 1991 to 31 December 1993, the authors have continued their efforts in all of these areas, as they feel that an integrated approach to the synthesis and characterization of new PET Radiopharmaceuticals is crucial to the continued growth and application of this imaging technique in modern medicine. Progress in a number of these areas is described in this report.

• Research Organization: Michigan Univ., Ann Arbor, MI (United States). Div. of Nuclear Medicine
• Sponsoring Organization: USDOE, Washington, DC (United States)
• DOE Contract Number: FG02-88ER60639
• OSTI ID: 10107772
• Report Number(s): DOE/ER/60639-T2; ON: DE94004194; BR: HA0207010/KP0601000
• Resource Relation: Other Information: PBD: Jun 1993
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY
RADIOPHARMACEUTICALS
CHEMICAL PREPARATION
FLUORINE 18
RADIOCHEMISTRY
ROBOTS
STRUCTURE-ACTIVITY RELATIONSHIPS
DOPAMINE
TISSUE DISTRIBUTION
LABELLING
CARBON 11
BRAIN
PROGRESS REPORT
550601
400703
UNSEALED RADIONUCLIDES IN DIAGNOSTICS
RADIOISOTOPE PRODUCTION